To use Oracle BIEE, please enable javascript in your browser.
The number of individual cases identified in EudraVigilance for COVID-19 VACCINE JANSSEN (AD26.COV2.S) is 70,626 (up to 07/01/2023)

Number of individual cases by Age Group

 
 
Pivot Table Prompts
 
Sections
 
Age Group
Cases
%
Not Specified 4,997 7.1%
0-1 Month 19 0.0%
2 Months - 2 Years 56 0.1%
3-11 Years 6 0.0%
12-17 Years 118 0.2%
18-64 Years 60,527 85.7%
65-85 Years 4,496 6.4%
More than 85 Years 407 0.6%
Total 70,626 100.0%

Number of individual cases by Sex

 
 
Pivot Table Prompts
 
Sections
 
Sex
Cases
%
Female 37,400 53.0%
Male 30,431 43.1%
Not Specified 2,795 4.0%
Total 70,626 100.0%

Number of individual cases by Geographic Origin (EEA/Non-EEA)

 
 
Pivot Table Prompts
 
Sections
 
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area 58,516 82.9%
Non European Economic Area 12,110 17.1%
Not Specified 0  
Total 70,626 100.0%

Number of individual cases by Reporter Group

 
 
Pivot Table Prompts
 
Sections
 
Reporter Group
Cases
%
Healthcare Professional 27,162 38.5%
Non Healthcare Professional 43,464 61.5%
Not Specified 0  
Total 70,626 100.0%
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu